Reply to Sfeir, "Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening: Clinical Use for Excluding Diabetic Foot Infection with MRSA"

Kari A Mergenhagen¹, Michael Croix², Kaitlyn E Starr³, John A Sellick^{4

5}, Alan J Lesse^{4

5

6}

Affiliations

¹ Department of Pharmacy, Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA karimergenhagen@gmail.com.
² Division of Internal Medicine and Pediatrics, University at Buffalo, Buffalo, New York, USA.
³ Department of Pharmacy, Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA.
⁴ Department of Infectious Diseases, Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA.
⁵ Jacobs School of Medicine and Biomedical Sciences, Department of Internal Medicine, University at Buffalo, Buffalo, New York, USA.
⁶ Jacobs School of Medicine and Biomedical Sciences, Department of Bioinformatics, University at Buffalo, Buffalo, New York, USA.

Comment

Kari A Mergenhagen et al. Antimicrob Agents Chemother. 2020.

. 2020 Jun 23;64(7):e00803-20.

doi: 10.1128/AAC.00803-20. Print 2020 Jun 23.

Kari A Mergenhagen¹, Michael Croix², Kaitlyn E Starr³, John A Sellick^{4

5}, Alan J Lesse^{4

5

6}

¹ Department of Pharmacy, Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA karimergenhagen@gmail.com.
² Division of Internal Medicine and Pediatrics, University at Buffalo, Buffalo, New York, USA.
³ Department of Pharmacy, Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA.
⁴ Department of Infectious Diseases, Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA.
⁵ Jacobs School of Medicine and Biomedical Sciences, Department of Internal Medicine, University at Buffalo, Buffalo, New York, USA.
⁶ Jacobs School of Medicine and Biomedical Sciences, Department of Bioinformatics, University at Buffalo, Buffalo, New York, USA.

No abstract available

Comment on

Utility of Methicillin-Resistant Staphylococcus aureus Nares Screening for Patients with a Diabetic Foot Infection.
Mergenhagen KA, Croix M, Starr KE, Sellick JA, Lesse AJ. Mergenhagen KA, et al. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02213-19. doi: 10.1128/AAC.02213-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 31988097 Free PMC article.
Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening: Clinical Use for Excluding Diabetic Foot Infection with MRSA.
Sfeir MM. Sfeir MM. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00635-20. doi: 10.1128/AAC.00635-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32393485 Free PMC article. No abstract available.

1. Mergenhagen KA, Croix M, Starr KE, Sellick JA, Lesse AJ. 2020. Utility of methicillin-resistant Staphylococcus aureus nares screening for patients with a diabetic foot infection. Antimicrob Agents Chemother 64:e02213-19. doi:10.1128/AAC.02213-19. - DOI - PMC - PubMed